A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
for Graves' Disease
Drug: IMVT-1402
89 locations incl. Phoenix
Sponsor: Immunovant Sciences GmbH
Sex: All·Age: 18+
Code: NCT07286006·Phase 2·Enrolling By Invitation